Recombinant Cynomolgus DNAM-1/CD226 Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 9276-DN
Key Product Details
Source
HEK293
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived cynomolgus monkey DNAM-1/CD226 protein
Cynomolgus Monkey DNAM-1/CD226 (Glu19-Asn247) Accession # XP_005586537 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Glu19
Predicted Molecular Mass
53 kDa
SDS-PAGE
74-87 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Cynomolgus Monkey DNAM-1/CD226 Fc Chimera is immobilized at 0.25 μg/mL (100 μL/well), the concentration of Recombinant Human CD155/PVR Fc Chimera (Catalog # 9174-CD) that produces 50% of the optimal binding response is approximately
0.2-1 μg/mL.
When Recombinant Cynomolgus Monkey DNAM-1/CD226 Fc Chimera is immobilized at 0.25 μg/mL (100 μL/well), the concentration of Recombinant Human CD155/PVR Fc Chimera (Catalog # 9174-CD) that produces 50% of the optimal binding response is approximately
0.2-1 μg/mL.
Scientific Data Images for Recombinant Cynomolgus DNAM-1/CD226 Fc Chimera Protein, CF
Recombinant Cynomolgus DNAM-1/CD226 Fc Chimera Protein Bioactivity
When Recombinant Cynomolgus Monkey DNAM-1/CD226 Fc Chimera (Catalog # 9276-DN) is immobilized at 0.25 µg/mL, 100 µL/well, Recombinant Human CD155/PVR Fc Chimera (Catalog # 9174-CD) binds with a typical ED50 of 0.2-1 µg/mL.Formulation, Preparation and Storage
9276-DN
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 1 mg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: DNAM-1/CD226
References
- Ceboni, C. et al. (2013) Front. Immunol. 4:508.
- Shibuya, A. et al. (1996) Immunity 4:573.
- Bottino, C. et al. (2003) J. Exp. Med. 198:557.
- Tahara-Hanaoka, S. et al. (2004) Int. Immunol. 16:533.
- Kojima, H. et al. (2003) J. Biol. Chem. 278:36748.
- Chan, C.J. et al. (2014) Nat. Immunol. 15:431.
- Bachelet, I. et al. (2006) J. Biol. Chem. 281:27190.
- Shibuya, K. et al. (1999) Immunity 11:615.
- Dardalhon, V. et al. (2005) J. Immunol. 175:1558.
- Lozano, E. et al. (2013) J. Immunol. 191:3673.
- Reymond, N. et al. (2004) J. Exp. Med. 199:1331.
- Kakehi, S. et al. (2007) Mol. Cell. Biochem. 301:209.
- Kojima, H. et al. (2003) J. Biol. Chem. 278:36748.
- Tahara-Hanaoka, S. et al. (2006) Blood 107:1491.
- Morimoto, K. et al. (2007) Oncogene 27:264.
- Carlsten, M. et al. (2009) J. Immunol. 183:4921.
Long Name
DNAX Accessory Molecule 1
Alternate Names
CD226, DNAM1, PTA1, TLiSA1
Gene Symbol
CD226
UniProt
Additional DNAM-1/CD226 Products
Product Documents for Recombinant Cynomolgus DNAM-1/CD226 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Cynomolgus DNAM-1/CD226 Fc Chimera Protein, CF
For research use only
Loading...
Loading...
Loading...